The adoption of new prescription drugs is strongly associated with prior category prescribing rate

Thumbnail Image
Date
2015-12-18
DOI
10.1016/j.ijresmar.2015.12.002
Open Access Location
https://ore.exeter.ac.uk/repository/handle/10871/31431
Authors
Wright MJ
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Rights
Abstract
We investigate whether doctors who adopt a new drug in its first year on the market tend to be heavier category prescribers. Early studies of pharmaceutical prescribing and packaged goods purchasing suggest that innovators are heavier category users; however, this finding has received little attention and the evidence remains sparse. We examine the adoption of 36 new drugs by doctors in the United Kingdom and find that, on average, the prior category prescribing rate of innovators is about 50% higher than that of non-innovators.
Description
Keywords
Differentiated replication, Extension, Adoption, Pharmaceuticals
Citation
INTERNATIONAL JOURNAL OF RESEARCH IN MARKETING, 2016, 33 (1), pp. 220 - 224
URI
Collections
Journal Articles